1. Ekelund P, Grimby A, Milsom I. Urinary incontinence: social and financial costs high. Br Med J. 1993;306:1344.
2. Irwin DE, Kopp ZS, Agatep B, et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8.
3. Milsom I, Coyne KS, Nicholson S, Kvasz M, Chen CI, Wein AJ. Global prevalence and economic burden of urgency urinary incontinence: a systematic review. Eur Urol. 2014;65(1):79–95.
4. Milsom I, Altman D, Cartwright R, Lapitan MC, Nelson R, Sjöström S, Tikkanen K. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 6th ed. London: Health Publications Ltd; 2017. p. 15–107.
5. Wagner TH, Moore K, Subak L, de Wachter S, Dudding T. Economics of urinary and faecal incontinence, and prolapse. In: Abrams P, Cardozo L, Wagg A, Wein A, editors. Incontinence. 6th ed. London: Health Publications Ltd; 2017. p. 15–107.